In all models, we simultaneously included
terms for age, time (eight periods), presence or absence of
a family history of diabetes, menopausal status, and use or nonuse
of postmenopausal hormone therapy. In the initial analyses, we
calculated the relative risks and 95 percent confidence intervals
31
for the different categories of each variable that was included in the
low-risk profile, adjusting for age, time, presence or absence of a
family history of diabetes, menopausal status, and use or nonuse of
postmenopausal hormone therapy but not for the other components
of the low-risk profile. We